Haleon
British multinational consumer healthcare company
HLN London SE · home listing
HLN NYSE
ISIN GB00BMX86B70 SEC CIK 1900304
Follow Haleon
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | £11B | £1.7B |
| FY24 | £11.2B | £1.4B |
| FY23 | £11.3B | £1B |
| FY22 | £10.9B | £1.1B |
| FY21 | £9.5B | £1.4B |
| FY20 | £9.9B | £1.1B |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 64.2% | 21.9% | 15.1% |
| FY24 | 60.7% | 19.6% | 12.8% |
| FY23 | 59.7% | 17.7% | 9.3% |
| FY22 | 60.6% | 16.8% | 9.8% |
| FY21 | 62.3% | 17.2% | 14.6% |
| FY20 | 59.7% | 16.2% | 11.6% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | £2.3B |
| FY24 | £2.1B |
| FY23 | £1.9B |
| FY22 | £1.8B |
| FY21 | £1.1B |
| FY20 | £1.2B |
| FY19 | - |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | £612M | - |
| FY24 | £570M | - |
| FY23 | £388M | £38M |
| FY22 | £2.7B | - |
| FY21 | £1.1B | - |
| FY20 | £2.4B | - |
| FY19 | - | - |
- Haleon
- Materials median
Show the numbers
| Year | Haleon | Materials median |
|---|---|---|
| FY25 | 15.1% | 2.3% |
| FY24 | 12.8% | 3.4% |
| FY23 | 9.3% | 4.4% |
| FY22 | 9.8% | 5.6% |
| FY21 | 14.6% | 6.4% |
| FY20 | 11.6% | 4.1% |
| FY19 | - | 4.1% |